23
4
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TQ0200 |
Paricalcitol
|
||
Paricalcitol 是一种 vitamin D receptor 激活剂,是一种 vitamin D 类似物,用于研究继发性甲状旁腺功能亢进,该疾病与慢性肾功能衰竭有关。 | |||
T16015 |
Maxacalcitol
马沙骨化醇,22-Oxacalcitriol |
Others | Others |
Maxacalcitol (22-Oxacalcitriol) 是非血钙维生素 D3的一种类似物,是 VDR 样受体的配体。 | |||
T6430L |
Calcifediol monohydrate
骨化二醇一水合物,25-hydroxy Vitamin D3 monohydrate |
Endogenous Metabolite | Metabolism |
Calcifediol monohydrate (25-hydroxy Vitamin D3 monohydrate) 是维生素 D3 在肝中经羟基化后得到的前激素,是有效的 VDR 抑制剂。 | |||
T14856 |
Calcipotriol
MC 903,卡泊三醇,Calcipotriene |
||
Calcipotriol (MC 903) 是一种合成的 VitD3类似物,对维他命 D 受体具有高亲和力。 | |||
TQ0244 |
Calcipotriol monohydrate
钙泊三醇一水合物,卡泊三醇一水合物 |
||
Calcipotriol monohydrate 是维生素 D3 的类似物,对维生素 D 受体具有高亲和力。Calcipotriol monohydrate 可用于银屑病研究。 | |||
T6374 |
Alfacalcidol
Bondiol,Etalpha,阿法骨化醇,1-hydroxy Vitamin D3,1.alpha.-Hydroxyvitamin D3,1-hydroxycholecalciferol |
Others | Others |
Alfacalcidol (Etalpha) 是一种维生素 D3 衍生物,是非选择性的维生素 D 受体活化剂,有用于骨质疏松研究的潜力。 | |||
T24166 |
Inecalcitol
TX 522,TX-522,TX522,伊奈骨化醇 |
Apoptosis | Apoptosis |
Inecalcitol (TX 522) 是一种独特的维生素 D3 类似物,可诱导细胞凋亡,有抗癌活性。它是一种具有口服活性维生素 D 受体激动剂,Kd 为 0.53 nM。 | |||
T6112 |
Doxercalciferol
TSA 840,度骨化醇,Hectorol,1.alpha.-Hydroxyvitamin D2,1α-hydroxyvitamin D2 |
Others | Others |
Doxercalciferol (TSA 840) 是一种维生素 D2 类似物,是一种维生素 D 受体激活剂,能够阻碍肾病的进程。 | |||
T19559 |
Seocalcitol
EB 1089 |
Others | Others |
Seocalcitol is an analog of vitamin D, binds vitamin D receptor protein from human osteosarcoma MG-63 cells(Kd : 0.27 nM). | |||
T23762 | Atocalcitol | ||
Atocalcitol is a vitamin D analog. It also acts as an agonist of alcitriol receptor. | |||
T13197 |
trans-Doxercalciferol
|
Others | Others |
trans-Doxercalciferol is an isomer of Doxercalciferol. Doxercalciferol is an activator of the Vitamin D receptor and prevents renal disease. | |||
T19227 |
Calcitriol Impurities A
|
Others | Others |
Calcitriol Impurities A refers to the contaminants found in Calcitriol, the hormonally active metabolite of vitamin D3, which serves to activate the vitamin D receptor. | |||
T27825 |
LG190178
LG-190178,LG 190178 |
||
LG190178, a vitamin D receptor (VDR) ligand, is a therapeutic agent used for the treatment of psoriasis, osteoporosis, and secondary hyperparathyroidism. | |||
T11643 |
Impurity B of Calcitriol
1β,25-Dihydroxyvitamin-D3,1-Epicalcitriol |
Others | Others |
Impurity B of Calcitriol is an impurity of Calcitriol. Calcitriol is the hormonally active form of vitamin D, Calcitriol is the active metabolite of vitamin D3 that activates the vitamin D receptor (VDR). | |||
T10663 |
Calcitriol-d6
Calcitriol D6,骨化三醇 D6 |
Others | Others |
Calcitriol D6 is the deuterated form of Calcitriol, which is the hormonally active form of vitamin D. Calcitriol is the active metabolite of vitamin D3 that activates the vitamin D receptor. | |||
T75085 | Doxercalciferol-d | ||
Doxercalciferol-d33是 Doxercalciferol 的氘化形式,是维生素 D2类似物,能作为维生素D 受体活化剂。 | |||
T11089 |
Doxercalciferol-D3
|
Others | Others |
Doxercalciferol-d3 is the deuterated form of Doxercalciferol and ACTS as vitamin D receptor activator (VDRA), which is a vitamin D2 analogue. | |||
T35524 |
(1S)-Calcitriol
|
||
(1S)-Calcitriol (1α,25-Dihydroxy-3-epi-vitamin-D3) is a natural metabolite of 1α,25-dihydroxyvitamin D3 (1α,25(OH)2D3). (1S)-Calcitriol exhibits potent vitamin D receptor (VDR)-mediated actions such as inhibition of keratinocyte growth or suppression of parathyroid hormone secretion[1]. 3‐epi‐Calcitroic acid is an end product of (1S)-Calcitriol (1α,25-Dihydroxy-3-epi-vitamin-D3; 3‐epi‐1a,25(OH)2D3) metabolism by rat CYP24A1[1]. [1]. Steve Y Rhieu, et al. Metabolic stability of 3-epi-1α,25-dihydr... | |||
T69676 | LG190155 | ||
LG190155 is a moderately potent VDR agonist. Vitamin D receptor (VDR) agonists are well known for their capacity to control calcium and bone metabolism and to regulate growth and differentiation of many cell types. | |||
T24407 |
LG190119
LG-190119,LG 190119 |
||
LG190119 is a nonsecosteroidal vitamin D receptor modulator. It effectively inhibited LNCaP xenograft tumor growth without increased serum calcium levels or any other apparent side effects. It also inhibits the growth of LNCaP xenograft tumors in athymic | |||
T78944 |
VDR agonist 2
|
||
VDR agonist 2(化合物16i)作为VDR(vitamin D receptor)激动剂,能有效抑制TGF-β1诱导的肝星状细胞(HSC)活化,并在体外和体内展现出显著的抗肝纤维化效果。 | |||
T36593 |
TEI-9648
|
||
TEI-9648, a Vitamin D3 Lactone analogue, is a potent and specific vitamin D receptor (VDR) antagonist. TEI-9648 inhibits VDR/VDRE-mediated genomic actions of 1α,25(OH)2D3. TEI-9648 also inhibits HL-60 cell differentiation induced by of 1α,25(OH)2D3. TEI-9648 has the potential for bone metabolism research[1][2]. TEI-9648 (10-1000 nM) dose-dependently blocks the reciprocal changes of CD11b and CD71 expression associated with HL-60 cell differentiation induced by 1α,25(OH)2D3[1]. TEI-9648 has cons... | |||
T13292 | VDR agonist 1 | Others | Others |
VDR agonist 1 (compound 28) 是一种非甾体类维生素 D 受体 (VDR)的激动剂, 在MCF-7 细胞中测得其IC50值为 690 nM。VDR agonist 1 通过上调 p21 和 p27 的表达来抑制细胞周期,通过增加 BAX 的表达来促进细胞凋亡,降低 Bcl-2 的表达,具有治疗乳腺癌的潜力。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1086 |
Vitamin D2
Calciferol,Ergocalciferol,Ercalciol,维生素D2 |
DNA/RNA Synthesis; Endogenous Metabolite | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Metabolism |
Vitamin D2 (Calciferol) 来源于植物或膳食补充剂,能够用作维生素 D 的补充剂。 | |||
T1135 |
Vitamin D3
维生素D3,Cholecalciferol,Colecalciferol |
Endogenous Metabolite | Metabolism |
Vitamin D3 (Cholecalciferol) 是维生素 D 的一种天然存在形式,代谢激活后可以诱导细胞分化和癌细胞增殖。 | |||
T6430 |
Calcifediol
25-羟基维生素 D3,U 32070E,25-hydroxy Vitamin D3,RO 8-8892,骨化二醇 |
Endogenous Metabolite | Metabolism |
Calcifediol (U 32070E) 是由维生素 D3 在肝中经羟基化后得到的前激素,是 VDR 的有效抑制剂。 | |||
T6316 |
Calcitriol
Topitriol,Rocaltrol,Calcijex,RO215535,骨化三醇,1,25-Dihydroxyvitamin D3 |
Endogenous Metabolite | Metabolism |
Calcitriol (1,25-Dihydroxyvitamin D3) 是一种维他命 D 的代谢物,一种维他命 D 受体 (VDR) 的激动剂 (IC50=0.4 nM)。Calcitriol 增加肠道对钙和磷的吸收,并与甲状旁腺激素一起增加了骨吸收。 |